Clinical Trials Browser

INDUSTRY × Carcinoma, Neuroendocrine × tocilizumab × Clear all

NCT05619744 2025-03-10

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

Phase 1 Completed

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma